Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Oculo-ectodermal syndrome (OES) is characterized by the association of epibulbar dermoids and aplasia cutis congenital.
Features include always present findings: Preauricular skin tag, Aplasia cutis congenita, and Hyperpigmented streaks; and very common findings: Limbal dermoid, Abnormal conjunctiva morphology, Agenesis of corpus callosum, and Absent septum pellucidum and others. 67 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 6 | Preauricular skin tag, Hyperpigmentation of the skin, Lymphedema |
KRAS encodes KRAS proto-oncogene, GTPase (189 aa). Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. Plays an important role in the regulation of cell proliferation. Highest expression in Nerve Tibial (30.7 TPM) and Brain Cerebellar Hemisphere (25.1 TPM).
Toriello-Lacassie-Droste syndrome is associated with mutations in the KRAS gene on chromosome 12.
KRAS is classified as a druggable target (Clinically Actionable, Drug Resistance, and Enzyme categories) with score 1.0.
Genetic testing for KRAS is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 3 always present features, 7 very common features, 27 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Toriello-Lacassie-Droste syndrome.
7 publications have been identified in PubMed for Toriello-Lacassie-Droste syndrome. Research spans Case Report / Case Series (43%), Review / Meta-Analysis (29%), and Other (14%).
Vincent M (2026). [PMID: 42151365](https://pubmed.ncbi.nlm.nih.gov/42151365/). *Commun Med (Lond)*. [Case Report / Case Series]
Potluri S (2026). [PMID: 41198137](https://pubmed.ncbi.nlm.nih.gov/41198137/). *Cornea*. [Other]
Hanna H (2025). [PMID: 39644163](https://pubmed.ncbi.nlm.nih.gov/39644163/). *Pediatr Dermatol*. [Case Report / Case Series]
Azrak O (2025). [PMID: 40750791](https://pubmed.ncbi.nlm.nih.gov/40750791/). *Am J Med Genet A*. [Case Report / Case Series]
Lopes FCPS (2024). [PMID: 39622606](https://pubmed.ncbi.nlm.nih.gov/39622606/). *Semin Pediatr Neurol*. [Review / Meta-Analysis]
Morren MA (2024). [PMID: 38290824](https://pubmed.ncbi.nlm.nih.gov/38290824/). *J Med Genet*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 7:51 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Toriello-Lacassie-Droste syndrome
Eyes |
4 |
Opacification of the corneal stroma, Strabismus, Nystagmus |
Brain and nerves | 4 | Seizure, Global developmental delay, Depressed nasal bridge |
Head and neck | 4 | Macrocephaly, Giant cell granuloma of mandible, Facial asymmetry |
Heart and blood vessels | 4 | Thickened heart muscle (hypertrophic cardiomyopathy), Transient ischemic attack, Atrial septal defect |
Muscles | 2 | Chorioretinal atrophy, Low muscle tone (hypotonia) |
Arms and legs | 2 | Limbal dermoid, Lower limb asymmetry |
Growth and development | 2 | Growth delay, Failure to thrive |
Ears | 2 | Hearing loss (hearing impairment), Abnormality of the ear |
Reproductive system | 1 | Abnormal nervous system morphology |
Digestive system | 1 | Feeding difficulties |
Grodecki BM (2024). [PMID: 38302056](https://pubmed.ncbi.nlm.nih.gov/38302056/). *Ophthalmol Retina*. [Epidemiology / Natural History]